Lupagen & Humanigen to explore point-of-care CAR-T therapy – PR Newswire (press release)
|
Lupagen & Humanigen to explore point-of-care CAR–T therapy
PR Newswire (press release) DALLAS, May 22, 2018 /PRNewswire/ — Lupagen, Inc. (www.lupagen.com), a medical device company developing first-in-class cell and gene therapy delivery technologies for CAR–T, gene editing and immunotherapy products, today announced the intent to … |
